title: pros-methylimidazoleacetic acid in rat brain: its regional distribution and relationship to metabolic pathways of histamine.
abstract: pros-Methylimidazoleacetic acid (p-MIAA; 1-methylimidazole-5-acetic acid), an isomer of the histamine metabolite, tele-methylimidazoleacetic acid (t-MIAA), is present in brain and CSF. Its relationship to histamine synthesis and catabolism was assessed in brains of rats. p-MIAA distribution in brain regions was heterogeneous although the concentrations in regions with the highest (hypothalamus) and the lowest (medulla-pons) levels differed less than four-fold. There was no significant correlation between the regional distributions of p-MIAA with those of histamine or its metabolites. pros-Methylhistidine (1 g/kg, i.p.) produced a 20-fold increase in mean levels of p-MIAA and up to a 50-fold increase in levels of pros-methylhistamine (p-MH), a putative intermediate; levels of histamine and its metabolites were unaltered. L-Histidine (1 g/kg, i.p.) or alpha-fluoromethylhistidine (100 mg/kg, i.p.), the irreversible inhibitor of histamine synthesis, did not alter the levels of p-MIAA in brain. Like the levels of t-MIAA, the levels of p-MIAA were unaltered after probenecid administration. Contrary to its effects in lowering t-MIAA levels, pargyline (75 mg/kg, i.p.) produced a slight rise in levels of p-MIAA in all regions. These findings suggest that, in brain, the metabolic pathways of histamine are independent of pathways that generate p-MIAA. Further, since brain is capable of p-MH formation, its use as an internal standard in analytical methods merits caution.
authors.affiliation: Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, New York.
authors.forename: G D
authors.initials: GD
authors.lastname: Prell
authors.forename: J K
authors.initials: JK
authors.lastname: Khandelwal
authors.forename: L B
authors.initials: LB
authors.lastname: Hough
authors.forename: J P
authors.initials: JP
authors.lastname: Green
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006632:Histamine / Q000378:metabolism*; D006639:Histidine / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism; D007093:Imidazoles / Q000378:metabolism*; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D008762:Methylhistidines / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010902:Pituitary Gland / Q000378:metabolism; D011149:Pons / Q000378:metabolism; D011339:Probenecid / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
chemical_list: D007093:Imidazoles; D008762:Methylhistidines; C055224:pros-methylimidazoleacetic acid; D006639:Histidine; C028309:alpha-fluoromethylhistidine; D006632:Histamine; D010293:Pargyline; D011339:Probenecid